Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis

  Free Subscription


10.09.2018

1 Arch Virol
3 Eur J Gastroenterol Hepatol
2 Gastroenterol Hepatol
3 Hepatology
3 J Hepatol
2 J Immunol
3 J Med Virol
2 J Pediatr
8 J Viral Hepat
1 J Virol
1 PLoS Comput Biol
4 PLoS One
1 Transplant Proc


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Arch Virol

  1. SULCZEWSKI FB, Liszbinski RB, Romao PRT, Rodrigues Junior LC, et al
    Nanoparticle vaccines against viral infections.
    Arch Virol. 2018 May 4. pii: 10.1007/s00705-018-3856.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  2. STOURNARAS E, Neokosmidis G, Stogiannou D, Protopapas A, et al
    Effects of antiviral treatment on the risk of hepatocellular cancer in patients with chronic viral hepatitis.
    Eur J Gastroenterol Hepatol. 2018 Sep 1. doi: 10.1097/MEG.0000000000001254.
    PubMed     Text format     Abstract available

  3. FUKUI A, Kawabe N, Hashimoto S, Kamei H, et al
    Skeletal muscle mass depletion in patients with hepatitis C virus infection.
    Eur J Gastroenterol Hepatol. 2018 Sep 1. doi: 10.1097/MEG.0000000000001255.
    PubMed     Text format     Abstract available

  4. ABDELAZIZ AO, Shousha HI, Said EM, A Soliman Z, et al
    Evaluation of liver steatosis, measured by controlled attenuation parameter, in patients with hepatitis C-induced advanced liver fibrosis and hepatocellular carcinoma.
    Eur J Gastroenterol Hepatol. 2018 Jul 17. doi: 10.1097/MEG.0000000000001196.
    PubMed     Text format     Abstract available


    Gastroenterol Hepatol

  5. ARAOS-BAERISWYL E, Moll-Manzur C
    Renal aspergillosis after liver transplant: Report of an unusual case.
    Gastroenterol Hepatol. 2017 Jan 11. pii: S0210-5705(16)30198.
    PubMed     Text format    

  6. SOLE C, Sola E
    Update on acute-on-chronic liver failure.
    Gastroenterol Hepatol. 2018;41:43-53.
    PubMed     Text format     Abstract available


    Hepatology

  7. WANG J, Chen J, Liu Y, Zeng X, et al
    Hepatitis B Virus Induces Autophagy to Promote its Replication by the Axis of miR-192-3p-XIAP via NF-kappaB Signaling.
    Hepatology. 2018 Sep 4. doi: 10.1002/hep.30248.
    PubMed     Text format     Abstract available

  8. KAO WY, Su CW, Tan EC, Lee PC, et al
    Proton Pump Inhibitors and Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B or C.
    Hepatology. 2018 Sep 2. doi: 10.1002/hep.30247.
    PubMed     Text format     Abstract available

  9. NGUYEN MH, Lim JK, Ozbay AB, Fraysse J, et al
    Advancing age and comorbidity in a United States insured population-based cohort of patients with chronic hepatitis B.
    Hepatology. 2018 Sep 2. doi: 10.1002/hep.30246.
    PubMed     Text format     Abstract available


    J Hepatol

  10. SERSTE T, Moreno C, Gustot T
    Reply to: "Prevalent acute-on-chronic liver failure and response to corticosteroids in alcoholic hepatitis".
    J Hepatol. 2018 Aug 29. pii: S0168-8278(18)32277.
    PubMed     Text format    

  11. ZHAO P
    Reply to: "Antiviral therapy in hepatitis B virus-infected immunotolerant children, exploring a new land".
    J Hepatol. 2018 Aug 30. pii: S0168-8278(18)32299.
    PubMed     Text format    

  12. ALY MOKHLES M
    Antiviral therapy in hepatitis B virus-infected immunotolerant children, exploring a new land.
    J Hepatol. 2018 Aug 31. pii: S0168-8278(18)32270.
    PubMed     Text format    


    J Immunol

  13. TOUT I, Gomes M, Ainouze M, Marotel M, et al
    Hepatitis B Virus Blocks the CRE/CREB Complex and Prevents TLR9 Transcription and Function in Human B Cells.
    J Immunol. 2018 Sep 5. pii: jimmunol.1701726. doi: 10.4049/jimmunol.1701726.
    PubMed     Text format     Abstract available

  14. JING ZT, Liu W, Wu SX, He Y, et al
    Hepatitis B Virus Surface Antigen Enhances the Sensitivity of Hepatocytes to Fas-Mediated Apoptosis via Suppression of AKT Phosphorylation.
    J Immunol. 2018 Aug 31. pii: jimmunol.1800732. doi: 10.4049/jimmunol.1800732.
    PubMed     Text format     Abstract available


    J Med Virol

  15. GUOPING D, Xiaoshan L, Musa TH, Yu J, et al
    The Nationwide Distribution and Trends of Hepatitis C Virus Genotypes in Mainland China.
    J Med Virol. 2018 Sep 7. doi: 10.1002/jmv.25311.
    PubMed     Text format     Abstract available

  16. SASAKI R, Meyer K, Moriyama M, Kato N, et al
    Rapid hepatitis C virus clearance by antivirals correlates with immune status of infected patients.
    J Med Virol. 2018 Sep 7. doi: 10.1002/jmv.25310.
    PubMed     Text format     Abstract available

  17. LI Y, Zeng Y, Zeng G, Li J, et al
    The Effects of Direct-Acting Antiviral Agents on the Frequency of Myeloid-Derived Suppressor Cells and Natural Killer Cells in Patients with Chronic Hepatitis C.
    J Med Virol. 2018 Sep 1. doi: 10.1002/jmv.25302.
    PubMed     Text format     Abstract available


    J Pediatr

  18. EPSTEIN RL, Sabharwal V, Wachman EM, Saia KA, et al
    Perinatal Transmission of Hepatitis C Virus: Defining the Cascade of Care.
    J Pediatr. 2018 Aug 28. pii: S0022-3476(18)30899.
    PubMed     Text format     Abstract available

  19. SCHWARZ KB, Karnsakul W
    The Long Journey to Eradication of Hepatitis C Virus Infection Should Begin with the Smallest Victims.
    J Pediatr. 2018 Aug 29. pii: S0022-3476(18)31110.
    PubMed     Text format    


    J Viral Hepat

  20. LAMPERTICO P, Brunetto MR, Craxi A, Gaeta GB, et al
    Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B 'e' antigen-negative chronic hepatitis B genotype D.
    J Viral Hepat. 2018 Sep 5. doi: 10.1111/jvh.12999.
    PubMed     Text format     Abstract available

  21. HONER ZU SIEDERDISSEN C, Maasoumy B, Cornberg M
    New viral biomarkers for Hepatitis B: Are we able to change practice?
    J Viral Hepat. 2018 Sep 5. doi: 10.1111/jvh.12993.
    PubMed     Text format     Abstract available

  22. CHAN HLY, Chan FWS, Hui AJ, Li MKK, et al
    Switching to Peginterferon for Chronic Hepatitis B Patients with Hepatitis B e Antigen Seroconversion on Entecavir - A Prospective Study.
    J Viral Hepat. 2018 Sep 5. doi: 10.1111/jvh.13000.
    PubMed     Text format     Abstract available

  23. VROLING H, Oordt-Speets AM, Madeddu G, Babudieri S, et al
    A systematic review on models of care effectiveness and barriers to Hepatitis C treatment in prison settings in the EU/EEA.
    J Viral Hepat. 2018 Sep 5. doi: 10.1111/jvh.12998.
    PubMed     Text format     Abstract available

  24. SUKRITI S, Choudhary MC, Maras JS, Sharma S, et al
    Extracellular Vesicles From Hepatitis B Patients Serve As Reservoir Of Hepatitis B Virus DNA.
    J Viral Hepat. 2018 Sep 5. doi: 10.1111/jvh.12995.
    PubMed     Text format     Abstract available

  25. VAN CAMPENHOUT MJH, Brouwer WP, Xie Q, Guo S, et al
    Long-term follow-up of patients treated with entecavir and peginterferon add-on therapy for HBeAg positive chronic hepatitis B infection: ARES long-term follow-up.
    J Viral Hepat. 2018 Sep 5. doi: 10.1111/jvh.12997.
    PubMed     Text format     Abstract available

  26. DUONG MC, McLaws ML
    Screening hemodialysis patients for hepatitis C in Vietnam: the inconsistency between common hepatitis C virus serological and virological tests.
    J Viral Hepat. 2018 Sep 5. doi: 10.1111/jvh.12994.
    PubMed     Text format     Abstract available

  27. RODGERS MA, Holzmayer V, Vallari A, Olivo A, et al
    Hepatitis C virus surveillance and identification of human pegivirus 2 in a large Cameroonian cohort.
    J Viral Hepat. 2018 Sep 5. doi: 10.1111/jvh.12996.
    PubMed     Text format     Abstract available


    J Virol

  28. BOEIJEN LL, Hou J, de Groen RA, Verbon A, et al
    Persistent replication of HIV, HCV and HBV results in distinct gene expression profiles by human NK cells.
    J Virol. 2018 Sep 5. pii: JVI.00575-18. doi: 10.1128/JVI.00575.
    PubMed     Text format     Abstract available


    PLoS Comput Biol

  29. QUADEER AA, Morales-Jimenez D, McKay MR
    Co-evolution networks of HIV/HCV are modular with direct association to structure and function.
    PLoS Comput Biol. 2018;14:e1006409.
    PubMed     Text format     Abstract available


    PLoS One

  30. GOYAL A, Romero-Severson EO
    Screening for hepatitis D and PEG-Interferon over Tenofovir enhance general hepatitis control efforts in Brazil.
    PLoS One. 2018;13:e0203831.
    PubMed     Text format     Abstract available

  31. SILVA CMD, Peder LD, Guelere AM, Horvath JD, et al
    Seroprevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) among human immunodeficiency virus (HIV)-infected patients in an HBV endemic area in Brazil.
    PLoS One. 2018;13:e0203272.
    PubMed     Text format     Abstract available

  32. XING YF, Zhou DQ, He JS, Wei CS, et al
    Clinical and histopathological features of chronic hepatitis B virus infected patients with high HBV-DNA viral load and normal alanine aminotransferase level: A multicentre-based study in China.
    PLoS One. 2018;13:e0203220.
    PubMed     Text format     Abstract available

  33. WANG YW, Shen ZZ, Jiang Y
    Comparison of ARIMA and GM(1,1) models for prediction of hepatitis B in China.
    PLoS One. 2018;13:e0201987.
    PubMed     Text format     Abstract available


    Transplant Proc

  34. WOJTOWICZ M, Wilkowski P, Hryniewiecka E, Cieciura T, et al
    Effect of Successful Treatment of Hepatitis C Virus Infection Recurrence With Direct-Acting Antiviral Agents on Physical Performance in Liver Transplant Recipients.
    Transplant Proc. 2018;50:2027-2030.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: